Terms: = Liver cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
1239 results:
1. Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.
Yuan Z; Li B; Liao W; Kang D; Deng X; Tang H; Xie J; Hu D; Chen A
Front Immunol; 2024; 15():1382520. PubMed ID: 38698857
[TBL] [Abstract] [Full Text] [Related]
2. Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors.
Liu M; Jin Q; Wang H; Li Y
Front Immunol; 2024; 15():1396927. PubMed ID: 38690276
[TBL] [Abstract] [Full Text] [Related]
3. Autonomous circadian rhythms in the human hepatocyte regulate hepatic drug metabolism and inflammatory responses.
March S; Nerurkar N; Jain A; Andrus L; Kim D; Whittaker CA; Tan EKW; Thiberge S; Fleming HE; Mancio-Silva L; Rice CM; Bhatia SN
Sci Adv; 2024 Apr; 10(17):eadm9281. PubMed ID: 38657074
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial.
Xu L; Chen J; Liu C; Song X; Zhang Y; Zhao H; Yan S; Jia W; Wu Z; Guo Y; Yang J; Gong W; Ma Y; Yang X; Gao Z; Zhang N; Zheng X; Li M; Su D; Chen M
BMC Med; 2024 Apr; 22(1):172. PubMed ID: 38650037
[TBL] [Abstract] [Full Text] [Related]
5. Single-cell analysis revealed a potential role of T-cell exhaustion in colorectal cancer with liver metastasis.
Ling T; Zhang C; Liu Y; Jiang C; Gu L
J Cell Mol Med; 2024 Apr; 28(8):e18341. PubMed ID: 38647235
[TBL] [Abstract] [Full Text] [Related]
6. [Research Progress of Cellular Lipid Droplets in Oral Diseases].
Xu S; Wei J; Xie J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):475-481. PubMed ID: 38645850
[TBL] [Abstract] [Full Text] [Related]
7. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
[TBL] [Abstract] [Full Text] [Related]
8. Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.
Zheng L; Wang Y; Liu Z; Wang Z; Tao C; Wu A; Li H; Xiao T; Li Z; Rong W
Cancer Med; 2024 Apr; 13(7):e7043. PubMed ID: 38572921
[TBL] [Abstract] [Full Text] [Related]
9. Developing risk models and subtypes of autophagy-associated LncRNAs for enhanced prognostic prediction and precision in therapeutic approaches for liver cancer patients.
Zhang LU; Chu J; Yu Y
Oncol Res; 2024; 32(4):703-716. PubMed ID: 38560571
[TBL] [Abstract] [Full Text] [Related]
10. A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses.
Zhang S; Qin O; Wu S; Xu H; Huang W; Hailiang S
Aging (Albany NY); 2024 Mar; 16(6):5545-5566. PubMed ID: 38517376
[TBL] [Abstract] [Full Text] [Related]
11. Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus.
Wu HX; Ding XY; Xu YW; Yu MH; Li XM; Deng N; Chen JL
World J Gastroenterol; 2024 Feb; 30(8):843-854. PubMed ID: 38516240
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Value of an Immune Long Non-Coding RNA Signature in liver Hepatocellular Carcinoma.
Kong R; Wang N; Zhou CL; Lu J
J Microbiol Biotechnol; 2024 Apr; 34(4):958-968. PubMed ID: 38494878
[TBL] [Abstract] [Full Text] [Related]
13. Hemochromatosis: Ferroptosis, ROS, Gut Microbiome, and Clinical Challenges with Alcohol as Confounding Variable.
Teschke R
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473913
[TBL] [Abstract] [Full Text] [Related]
14. Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma.
Liu F; Brown DR; Munley MT
Radiother Oncol; 2024 May; 194():110223. PubMed ID: 38467342
[TBL] [Abstract] [Full Text] [Related]
15. Postabsorptive and postprandial glucose and fat metabolism in postmenopausal women with breast cancer-Preliminary data after chemotherapy compared to healthy controls.
Buch-Larsen K; Gillberg L; Ahmed HI; Marstrand SD; Andersson M; van Hall G; Brøns C; Schwarz P
Nutrition; 2024 Jun; 122():112394. PubMed ID: 38458062
[TBL] [Abstract] [Full Text] [Related]
16. Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma.
Zhang Q; Zhu B; Yang H; Li F; Qu Y; Lu L; Zhang Q
J Gene Med; 2024 Mar; 26(3):e3680. PubMed ID: 38448368
[TBL] [Abstract] [Full Text] [Related]
17. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
[TBL] [Abstract] [Full Text] [Related]
18. Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma.
Li X; Su H; Tang W; Shu S; Zhao L; Sun J; Fan H
Invest New Drugs; 2024 Apr; 42(2):185-195. PubMed ID: 38372948
[TBL] [Abstract] [Full Text] [Related]
19. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract] [Full Text] [Related]
20. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
[TBL] [Abstract] [Full Text] [Related]
[Next]